The inaugural Emerging Non-Coding RNA Therapeutics Summit is the only industry-dedicated summit focused on therapeutic and translational opportunities offered by non-coding RNAs...
Read More »Monthly Archives: July 2022
Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board
Amaroq Therapeutics, a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer, is progressing towards clinical trials following a promising initial development..
Read More »